Removal of vanadium by combining desferrioxamine and deferiprone chelators in rats

Medicinal Chemistry Research

Volumn 19, Issue 8, 2010, Pages 854-863

  Tubafard, Solmaz ^a   Fatemi, S Jamilaldine ^a   Saljooghi, Amir Shokooh ^a   Torkzadeh, Masoud ^b  

^a SHAHID BAHONAR UNIVERSITY OF KERMAN   (Iran)

^b International Center for Science and High Technology and Environmental Sciences Iran   (Iran)

Author keywords

Deferiprone; Desferrioxamine; Detoxification; Vanadium toxicity

Indexed keywords

CHELATING AGENT; DEFERIPRONE; DEFEROXAMINE; IRON; VANADIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BILIARY EXCRETION; BLOOD LEVEL; CHELATION THERAPY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG SCREENING; FLAME ATOMIC ABSORPTION SPECTROSCOPY; GRAPHITE FURNACE ATOMIC ABSORPTION SPECTROSCOPY; LIVER LEVEL; MALE; NONHUMAN; RAT; TISSUE LEVEL; URINARY EXCRETION;

EID: 77956502550     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00044-009-9235-3     Document Type: Article

References (23)

1. Barman Balfour JA, Foster RH (1999) Deferiprone: a review of its clinical potential in iron overload in β-thalassemia major and other transfusion-dependant diseases. Drugs 58:553-578
2. Berdoukas V, Bentlev P, Frost H, Schnebli HP (1993) Toxicol of oral iron chelator L1. Lancet 341:1088-1093
3. Bosque MA, Domingo JL, Corbella J (1995) Assessment of the developmental toxicity of desferrioxamine in mice. Arch Toxicol 69:871-872
4. Clarke ET, Martell AE (1992) Stabilities of 1, 2-dimethyl-3-hydroxypyrid- 4-one chelates of divalent and trivalent metal ions. Inorg Chim Acta 19:57-63
5. Domingo JL (1996) A review of the reproductive and developmental toxicity of vanadium. Reprod Toxicol 10(3):175-182
6. Domingo JL, Liobet JM, Tomaz JM, Corbella J (1986) Influence of chelating agents on the toxicity, distribution and excretion of vanadium in mice. J Appl Toxicol 6(5):337-341
7. Flora SJS, Bhattacharayan R, Vijayaraghavan R (1995) combined therapeutic potential of mesodimercaptosuccinic acid and calcium edentate on the mobilization and distribution of lead in experimental lead intoxication in rats. Fund Appl Toxicol 25:233-240
8. Gomez M, Domingo JL, Liobet JM, Corbella J (1991) Effectiveness of some chelating agents on distribution and excretion of vanadium in rats after prolonged oral administration. J Appl Toxicol 11(3):195-198
9. Gomez M, Domingo JL, Liobet JM, Paternain JL (1988a) Effectiveness of chelation therapy with time after acute vanadium intoxication. J Appl Toxicol 8(6):439-444
10. Gomez W, Esparza JL, Domingo JL, Singha PK, Jones MM (1988b) Comparative aluminum mobilizing action of desferrioxamine and four 3-hydroxypyrid-4-ones in aluminum-loaded rats. Toxicol 130: 175-181
11. Gomez W, Esparza JL, Domingo JL, Singh PK, Corbella J, Jones MM (1988c) Alminium distribution: a comparative study of a number of chelating agent in rats. Pharmacol Toxicol 82:295-300
12. Hershko C (2002) Role of iron chelation therapy in thalassemia major. Turk J Haematol 19(2):121-126
13. Hershko C, Link G, Konun AM, Ioav CZ (2005) Objectives and mechanism of iron chelation therapy. Ann N Y Acad Sci 1054:124-135
14. Ishida O, Tsukamoto Y, Marumo F (1989) Improved determination of vanadium in biological fluids by electrothermal atomic absorption spectrometry. Clin Chem 35(1):127-130
15. Kim JS, Cho EW, Chung HW, Kim IG (2006) Effects of tiron, 4, 5- dihydroxy-1, 3-benzene disulfonic acid on human promyelotic HL-60 leukemia cell differentiation and death. Toxicol 223:36-45
16. Kontoghiorghes GJ (1995) New concepts of iron and aluminum chelation therapy with orally L1 (deferiprone) and other chelators. Analyst 120:845-851
17. Kontoghiorghes GJ (2006) Future chelation monotherapy and combination therapy strategies in thalassemia and other conditions. Comparison of deferiprone, desferrioxamine, ICL670, GT 56-252
18. L1NAll and starch desferrioxamine polymers. Hemoglobin 30:329-347
19. Kontoghiorghes GJ, Sheppard L (1987) Simple synthesis of the potent chelators l-alkyl-3-hydroxy-2-mehylpyrid-4-ones. Inorg Chem Acta 136:111-112
20. Kostial K, Piasek M, Blanusa M, Schonwald N, Jones MM, Singha PK (1996) Combined treatment with a new biscarbodithioate C9G2DTC and BGDTC for mobilizing cadmium deposit in rats. J Appl Toxicol 16:157-158
21. Kostial K, Restek-Samarzija K, Blaanusa B, Piasek M, Jones MM, Singha PK (1997) Combined oral treatment with racemic and meso-2, 3 dimercaptosuccinic acid for removal of mercury in rats. Pharmacol Toxicol 81:242-244
22. Szakmary E, Naray M, Tatrai E, Hudak A, Ungvary G (2002) Developmental toxicity of orally administered vanadium pentoxide in rats and rabbits. Cent Eur J Occup Environ 8(4):310-321
23. Tor VH, Aaseth J, Alexander J (1982) The effect of chelating agents on vanadium distribution in the rat body and on uptake by human erythrocytes. Arch Toxicol 50(3-4):195-202